老年综合评估在老年肿瘤病人中的应用被引量：5

在线阅读下载PDF

导出

摘要恶性肿瘤与机体衰老有关,在老年人群中高发,是老年人的常见病,也是主要的死亡原因。由于老年人常多病共存,恶性肿瘤的症状有时不明显,在治疗过程中,多病体质又影响病人对药物治疗的耐受性[1]。因此,对于老年肿瘤病人,需要评估病人的功能状态,以指导病人选择合理的化疗方案。老年综合评估(comprehensive geriatric assessment,CGA)已在国际上被广泛认可,应用综合评估可以反映病人自身的功能状态。

作者吴新春殷实陈尹徐婷娟胡世莲姜晓东

机构地区中国科技大学附属第一医院(安徽省立医院)老年病研究室中国科技大学附属第一医院(安徽省立医院)老年医学科中国科技大学附属第一医院(安徽省立医院)瘤化疗科安徽省循证医学中心

出处《实用老年医学》 CAS 2019年第8期813-816,共4页 Practical Geriatrics

基金安徽省科技攻关项目(1501041142) 安徽省重点实验室绩效项目(S20180505050020) 安徽省科技重大专项项目(16030901057) 中国科技大学联合基金培育项目(WK9110000047)

关键词老年综合评估老年肿瘤病人功能状态死亡原因老年人群恶性肿瘤需要评估多病共存

分类号 R592 [医药卫生—老年医学]

引文网络
相关文献

参考文献5

1宋长城,张婷,吕颖钺.老年综合评估在老年肿瘤患者中应用的研究进展[J].现代肿瘤医学,2018,26(4):644-648. 被引量：10
2张春丽,冯茹,李江涛,田园,王婷,刘辉.综合性老年评估体系对中国老年弥漫大B细胞淋巴瘤患者的预后价值[J].中华血液学杂志,2018,39(4):271-276. 被引量：9
3李琳,别志欣,张萍,王晖,张子瑾,武小楠,程刚.高龄晚期非小细胞肺癌患者112例临床分析[J].中国临床保健杂志,2014,17(5):536-538. 被引量：9
4薛冬,许轶琛,蒋姗彤,孙红,李元青,李占东,王薇,王珂,张伟,李萍萍.关于老年肿瘤学与老年肿瘤康复事业的中外对话——根据一项回顾性研究分析开展老年肿瘤综合评估的意义[J].世界科学技术-中医药现代化,2015(12):2451-2457. 被引量：6
5陈晓琳,尹震宇,郭美姿.老年综合评估在老年肿瘤患者中的应用[J].中国老年学杂志,2014,34(7):2004-2007. 被引量：16

二级参考文献19

1Breen D, Barlesi F,Zemedi M,et al. Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged > 80 years [ J ]. Clin Lung Cancer,2007,8 ( 5 ) : 331-334.
2Koumarianou A, Fountzilas G, Kosmidis P, et al. Non small ceU lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients [ J ]. J Chemother, 2009,21 ( 5 ) : 573- 583.
3Cedres S, Nunez I, Longo M, et al. Serum tumor markers CEA,CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC) [ J]. Clin Lung Cancer,2011,12( 3 ) : 172-179.
4Janssen-Heijnen ML, Smulders S, Lemmens VE, et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer[ J]. Tho- rax, 2004,59 (7) : 602 -607.
5Tamiya A, Naito T, Ono A, et al. Evaluation of the efficacy and safety of chemotherapy for patients with wet stage II- IB/IV non-small-cell lung cancer aged 80 years old or morel[J]. Lung Cancer ,ZOI I ,71 (2) : 173-177.
6Kawaguchi T, Tamiya A, Tamura A, et al. Chemotherapy is beneficial for elderly patients with advanced non-small- cell lung cancer: analysis of patients aged 70-74,75-79, and 80 or older in Japan [ J ]. Clin Lung Cancer,2012,13 (6) :442-447.
7Langer C J, Vangel M, Schiller J. Age-specific sub-analysis of ECOG 1594: Fit elderly patients (70-80 years )with NSCLC do as well as younger patients ( < 70) [ J ]. Proc Am Soc Clin Oncol,2003,22(3) :639.
8Maione P: Rossi A, Sacco PC, et al. Treating advanced non-small cell lung cancer in the elderly [ J ]. Ther Adv Med Oncol, 2010,2 (4) : 251-260.
9Fisher MD,DOrazio A. Phase II and III trials:comparison of four chemotherapy regimens in advanced non small-cell lung cancer ( ECOG 1594) [ J ]. Clin Lung Cancer,2000, 2(1) :21-22.
10Hesketh PJ, Lilenbaum RC, Chansky K, et al. Chemothera- py in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6 [ J ]. J Thorac Oncol, 2007,2 ( 6 ) :494 -498.